Holdings of Franklin Genomic Advancements ETF
Franklin Templeton ETF Trust · Original filing · Compare with another fund · Report an error
- Net assets
- 21.4M $ including 20.6M $ in equities, 96.0 %
- Positions
- 58 in 8 countries
- Top ten
- 45.2 % of net assets
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Guardant Health Inc | 15,718 | 1.5M $ | 6.77 % |
| 2 | Natera Inc | 7,131 | 1.4M $ | 6.65 % |
| 3 | Krystal Biotech Inc | 4,418 | 1.1M $ | 5.32 % |
| 4 | United Therapeutics Corp | 1,680 | 996.2K $ | 4.65 % |
| 5 | Insmed Inc | 5,932 | 970K $ | 4.52 % |
| 6 | Bridgebio Pharma Inc | 12,192 | 905.4K $ | 4.22 % |
| 7 | Ligand Pharmaceuticals Inc | 3,794 | 757.5K $ | 3.53 % |
| 8 | AstraZeneca PLC | 3,695 | 728.7K $ | 3.40 % |
| 9 | Adaptive Biotechnologies Corp | 48,245 | 669.6K $ | 3.12 % |
| 10 | Vertex Pharmaceuticals Inc | 1,435 | 640.8K $ | 2.99 % |
| 11 | Samsung Biologics Co Ltd | 652 | 640.2K $ | 2.99 % |
| 12 | Medpace Holdings Inc | 1,327 | 637.2K $ | 2.97 % |
| 13 | Regeneron Pharmaceuticals, Inc. | 748 | 577.9K $ | 2.69 % |
| 14 | Corteva Inc | 6,904 | 577.9K $ | 2.69 % |
| 15 | Alnylam Pharmaceuticals Inc | 1,687 | 558.2K $ | 2.60 % |
| 16 | Eli Lilly & Co | 593 | 545.4K $ | 2.54 % |
| 17 | Ionis Pharmaceuticals Inc | 5,957 | 447.3K $ | 2.09 % |
| 18 | Tempus AI Inc | 8,726 | 394.6K $ | 1.84 % |
| 19 | BioNTech SE | 4,340 | 385.7K $ | 1.80 % |
| 20 | Neurocrine Biosciences Inc | 2,693 | 354.8K $ | 1.65 % |
| 21 | Stoke Therapeutics Inc | 10,539 | 343.1K $ | 1.60 % |
| 22 | Twist Bioscience Corp | 7,184 | 341.4K $ | 1.59 % |
| 23 | Argenx SE | 459 | 328.3K $ | 1.53 % |
| 24 | PTC Therapeutics Inc | 4,652 | 316.9K $ | 1.48 % |
| 25 | Travere Therapeutics Inc | 10,129 | 300.9K $ | 1.40 % |
| 26 | Charles River Laboratories International Inc | 1,445 | 249.3K $ | 1.16 % |
| 27 | CRISPR Therapeutics AG | 4,671 | 222.2K $ | 1.04 % |
| 28 | Repligen Corp | 1,866 | 219.9K $ | 1.03 % |
| 29 | Veracyte Inc | 6,788 | 218.6K $ | 1.02 % |
| 30 | Praxis Precision Medicines Inc | 667 | 214.9K $ | 1.00 % |
| 31 | GRAIL Inc | 4,138 | 213.9K $ | 1.00 % |
| 32 | Danaher Corp | 1,050 | 199.1K $ | 0.93 % |
| 33 | Thermo Fisher Scientific Inc | 391 | 192.2K $ | 0.90 % |
| 34 | IQVIA Holdings Inc | 1,005 | 171.4K $ | 0.80 % |
| 35 | Beam Therapeutics Inc | 7,036 | 167.7K $ | 0.78 % |
| 36 | Jazz Pharmaceuticals PLC | 841 | 159K $ | 0.74 % |
| 37 | Catalyst Pharmaceuticals Inc | 6,375 | 157.8K $ | 0.74 % |
| 38 | Cadence Design Systems Inc | 545 | 151.4K $ | 0.71 % |
| 39 | Agilent Technologies Inc | 1,136 | 129.5K $ | 0.60 % |
| 40 | CareDx Inc | 7,429 | 129K $ | 0.60 % |
| 41 | QIAGEN NV | 3,175 | 127.1K $ | 0.59 % |
| 42 | AnaptysBio Inc | 2,041 | 113.2K $ | 0.53 % |
| 43 | Samsung Episholdings Co Ltd | 350 | 112.9K $ | 0.53 % |
| 44 | Tarsus Pharmaceuticals Inc | 1,487 | 104.3K $ | 0.49 % |
| 45 | Ultragenyx Pharmaceutical Inc | 4,765 | 99.8K $ | 0.47 % |
| 46 | Arcutis Biotherapeutics Inc | 4,107 | 96.8K $ | 0.45 % |
| 47 | Axsome Therapeutics Inc | 566 | 95.7K $ | 0.45 % |
| 48 | GeneDx Holdings Corp | 1,409 | 90.5K $ | 0.42 % |
| 49 | Rhythm Pharmaceuticals Inc | 974 | 84.7K $ | 0.40 % |
| 50 | Hinge Health Inc | 2,182 | 84.1K $ | 0.39 % |
| 51 | Bristol-Myers Squibb Co | 1,111 | 67.4K $ | 0.31 % |
| 52 | Bio-Rad Laboratories Inc | 226 | 63K $ | 0.29 % |
| 53 | BEONE MEDICINES LTD | 209 | 62.1K $ | 0.29 % |
| 54 | TransMedics Group Inc | 482 | 47.9K $ | 0.22 % |
| 55 | Neurogene Inc | 1,840 | 37.1K $ | 0.17 % |
| 56 | WaVe Life Sciences Ltd | 4,470 | 32.4K $ | 0.15 % |
| 57 | Recursion Pharmaceuticals Inc | 10,393 | 31.9K $ | 0.15 % |
| 58 | Caris Life Sciences Inc | 557 | 10K $ | 0.05 % |
Sector breakdown
- Health care 38.7 %
- Materials 2.8 %
- Technology 0.7 %
- Unattributed 57.7 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 94.7 %
- KRW 3.7 %
- EUR 1.6 %
The quoted currency of each line, as declared.
Country breakdown
- United States 87.3 %
- South Korea 3.7 %
- United Kingdom 3.5 %
- Germany 1.9 %
- Belgium 1.6 %
- Switzerland 1.1 %
- Ireland 0.8 %
- Singapore 0.2 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 50 | 18M $ | 87.33 % |
| 2 | South Korea | 2 | 753.1K $ | 3.66 % |
| 3 | United Kingdom | 1 | 728.7K $ | 3.54 % |
| 4 | Germany | 1 | 385.7K $ | 1.87 % |
| 5 | Belgium | 1 | 328.3K $ | 1.59 % |
| 6 | Switzerland | 1 | 222.2K $ | 1.08 % |
| 7 | Ireland | 1 | 159K $ | 0.77 % |
| 8 | Singapore | 1 | 32.4K $ | 0.16 % |
Cite this page
Titelia. "Holdings of Franklin Genomic Advancements ETF". https://titelia.com/en/funds/S000067393